AAAAAA

   
Results: 1-11 |
Results: 11
NEUTRALIZING ANTIBODY-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PRIMARY INFECTION AND LONG-TERM-NONPROGRESSIVE INFECTION
Authors: PILGRIM AK PANTALEO G COHEN OJ FINK LM ZHOU JY ZHOU JT BOLOGNESI DP FAUCI AS MONTEFIORI DC
Citation: Ak. Pilgrim et al., NEUTRALIZING ANTIBODY-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PRIMARY INFECTION AND LONG-TERM-NONPROGRESSIVE INFECTION, The Journal of infectious diseases, 176(4), 1997, pp. 924-932
PATHOGENICITY MECHANISM OF RECOMBINANT VIRUS OF SUBSTITUTING LTR REGION OF NEW MURINE LEUKEMIC VIRUS (SRSV) INTO MOLENEY MURINE LEUKEMIA-VIRUS (MO-MLV)
Authors: ZHENG BF CHEN XH DONG Y ZHOU JT
Citation: Bf. Zheng et al., PATHOGENICITY MECHANISM OF RECOMBINANT VIRUS OF SUBSTITUTING LTR REGION OF NEW MURINE LEUKEMIC VIRUS (SRSV) INTO MOLENEY MURINE LEUKEMIA-VIRUS (MO-MLV), Progress in Biophysics and Molecular Biology, 65, 1996, pp. 117-117
COMPLEMENT-ACTIVATING ANTIBODIES IN SERA FROM INFECTED INDIVIDUALS AND VACCINATED VOLUNTEERS THAT TARGET HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO COMPLEMENT RECEPTOR-TYPE-1 (CR-1, CD35)
Authors: ZHOU JT MONTEFIORI DC
Citation: Jt. Zhou et Dc. Montefiori, COMPLEMENT-ACTIVATING ANTIBODIES IN SERA FROM INFECTED INDIVIDUALS AND VACCINATED VOLUNTEERS THAT TARGET HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO COMPLEMENT RECEPTOR-TYPE-1 (CR-1, CD35), Virology, 226(1), 1996, pp. 13-21
NEUTRALIZING AND INFECTION-ENHANCING ANTIBODY-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN LONG-TERM NONPROGRESSORS
Authors: MONTEFIORI DC PANTALEO G FINK LM ZHOU JT ZHOU JY BILSKA M MIRALLES GD FAUCI AS
Citation: Dc. Montefiori et al., NEUTRALIZING AND INFECTION-ENHANCING ANTIBODY-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN LONG-TERM NONPROGRESSORS, The Journal of infectious diseases, 173(1), 1996, pp. 60-67
MECHANISM OF RESISTANCE OF HIV-1 AND SIV TO COMPLEMENT LYSIS - THE ROLE OF ANTI-CELL ANTIBODIES IN VACCINE PROTECTION
Authors: MONTEFIORI DC CORNELL RJ ZHOU JY ZHOU JT HIRSCH VM JOHNSON PR
Citation: Dc. Montefiori et al., MECHANISM OF RESISTANCE OF HIV-1 AND SIV TO COMPLEMENT LYSIS - THE ROLE OF ANTI-CELL ANTIBODIES IN VACCINE PROTECTION, AIDS research and human retroviruses, 10, 1994, pp. 190000135-190000135
BINDING OF HIV-1 TO THE C3B C4B RECEPTOR, CR-1 (CD35), IN THE PRESENCE OF COMPLEMENT AND ANTIBODIES FROM INFECTED INDIVIDUALS AND GP160-VACCINATED VOLUNTEERS/
Authors: MONTEFIORI DC ZHOU JY ZHOU JT AHEARN JM
Citation: Dc. Montefiori et al., BINDING OF HIV-1 TO THE C3B C4B RECEPTOR, CR-1 (CD35), IN THE PRESENCE OF COMPLEMENT AND ANTIBODIES FROM INFECTED INDIVIDUALS AND GP160-VACCINATED VOLUNTEERS/, AIDS research and human retroviruses, 10, 1994, pp. 190000041-190000041
COMPLEMENT CONTROL PROTEINS, CD46, CD55, AND CD59, AS COMMON SURFACE CONSTITUENTS OF HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUSES AND POSSIBLETARGETS FOR VACCINE PROTECTION
Authors: MONTEFIORI DC CORNELL RJ ZHOU JY ZHOU JT HIRSCH VM JOHNSON PR
Citation: Dc. Montefiori et al., COMPLEMENT CONTROL PROTEINS, CD46, CD55, AND CD59, AS COMMON SURFACE CONSTITUENTS OF HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUSES AND POSSIBLETARGETS FOR VACCINE PROTECTION, Virology, 205(1), 1994, pp. 82-92
BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO THE C3B C4B RECEPTOR CR-1 (CD35) AND RED-BLOOD-CELLS IN THE PRESENCE OF ENVELOPE-SPECIFICANTIBODIES AND COMPLEMENT/
Authors: MONTEFIORI DC GRAHAM BS ZHOU JY ZHOU JT AHEARN JM
Citation: Dc. Montefiori et al., BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO THE C3B C4B RECEPTOR CR-1 (CD35) AND RED-BLOOD-CELLS IN THE PRESENCE OF ENVELOPE-SPECIFICANTIBODIES AND COMPLEMENT/, The Journal of infectious diseases, 170(2), 1994, pp. 429-432
V3-SPECIFIC NEUTRALIZING ANTIBODIES IN SERA FROM HIV-1 GP160-IMMUNIZED VOLUNTEERS BLOCK VIRUS ATTACHMENT AND ACT SYNERGISTICALLY WITH HUMANMONOCLONAL-ANTIBODY TO THE CONFORMATION-DEPENDENT CD4 BINDING REGION OF GP120
Authors: MONTEFIORI DC ZHOU JT BUCCO R ZHOU JY CAVACINI LA POSNER MR
Citation: Dc. Montefiori et al., V3-SPECIFIC NEUTRALIZING ANTIBODIES IN SERA FROM HIV-1 GP160-IMMUNIZED VOLUNTEERS BLOCK VIRUS ATTACHMENT AND ACT SYNERGISTICALLY WITH HUMANMONOCLONAL-ANTIBODY TO THE CONFORMATION-DEPENDENT CD4 BINDING REGION OF GP120, AIDS research and human retroviruses, 9, 1993, pp. 190000079-190000079
DETERMINATION OF OVER-ALL PROTONATION CON STANTS FOR TETRAPHENYLPORPHYRIN AND ITS DERIVATIVES BY SPECTROMETRY
Authors: YAN XC ZHOU JT LUO MD QU SS HUANG SQ ZENG FQ ZHANG YJ
Citation: Xc. Yan et al., DETERMINATION OF OVER-ALL PROTONATION CON STANTS FOR TETRAPHENYLPORPHYRIN AND ITS DERIVATIVES BY SPECTROMETRY, Huaxue xuebao, 51(10), 1993, pp. 994-998
V3-SPECIFIC NEUTRALIZING ANTIBODIES IN SERA FROM HIV-1 GP160-IMMUNIZED VOLUNTEERS BLOCK VIRUS FUSION AND ACT SYNERGISTICALLY WITH HUMAN MONOCLONAL-ANTIBODY TO THE CONFORMATION-DEPENDENT CD4 BINDING-SITE OF GP120
Authors: MONTEFIORI DC GRAHAM BS ZHOU JT ZHOU JY BUCCO RA SCHWARTZ DH CAVACINI LA POSNER MR
Citation: Dc. Montefiori et al., V3-SPECIFIC NEUTRALIZING ANTIBODIES IN SERA FROM HIV-1 GP160-IMMUNIZED VOLUNTEERS BLOCK VIRUS FUSION AND ACT SYNERGISTICALLY WITH HUMAN MONOCLONAL-ANTIBODY TO THE CONFORMATION-DEPENDENT CD4 BINDING-SITE OF GP120, The Journal of clinical investigation, 92(2), 1993, pp. 840-847
Risultati: 1-11 |